[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

NO20065290L - Fremgangsmate for a rense plasmid-DNA - Google Patents

Fremgangsmate for a rense plasmid-DNA

Info

Publication number
NO20065290L
NO20065290L NO20065290A NO20065290A NO20065290L NO 20065290 L NO20065290 L NO 20065290L NO 20065290 A NO20065290 A NO 20065290A NO 20065290 A NO20065290 A NO 20065290A NO 20065290 L NO20065290 L NO 20065290L
Authority
NO
Norway
Prior art keywords
order
purification steps
plasmid dna
pdna
continuous
Prior art date
Application number
NO20065290A
Other languages
English (en)
Norwegian (no)
Inventor
Michel Couder
Francis Blanche
Nicolas Maestrali
David Gaillac
Thierry Guillemin
Original Assignee
Centelion
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centelion filed Critical Centelion
Publication of NO20065290L publication Critical patent/NO20065290L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/10Protozoa; Culture media therefor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A61K48/0091Purification or manufacturing processes for gene therapy compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/10Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1003Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor
    • C12N15/1006Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor by means of a solid support carrier, e.g. particles, polymers
    • C12N15/101Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor by means of a solid support carrier, e.g. particles, polymers by chromatography, e.g. electrophoresis, ion-exchange, reverse phase
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/26Preparation of nitrogen-containing carbohydrates
    • C12P19/28N-glycosides
    • C12P19/30Nucleotides
    • C12P19/34Polynucleotides, e.g. nucleic acids, oligoribonucleotides
    • CCHEMISTRY; METALLURGY
    • C02TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02FTREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02F2303/00Specific treatment goals
    • C02F2303/06Sludge reduction, e.g. by lysis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physics & Mathematics (AREA)
  • Manufacturing & Machinery (AREA)
  • Epidemiology (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
NO20065290A 2004-04-19 2006-11-17 Fremgangsmate for a rense plasmid-DNA NO20065290L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US56300804P 2004-04-19 2004-04-19
PCT/EP2005/005213 WO2005100542A1 (en) 2004-04-19 2005-04-19 Method for purifying plasmid dna

Publications (1)

Publication Number Publication Date
NO20065290L true NO20065290L (no) 2006-11-17

Family

ID=40635654

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20065290A NO20065290L (no) 2004-04-19 2006-11-17 Fremgangsmate for a rense plasmid-DNA

Country Status (16)

Country Link
US (1) US20070213289A1 (pt)
JP (2) JP2007532123A (pt)
KR (1) KR20060135062A (pt)
CN (2) CN102031258A (pt)
AT (1) ATE496990T1 (pt)
AU (2) AU2005233309B2 (pt)
BR (1) BRPI0509490A (pt)
CA (1) CA2559368A1 (pt)
DE (1) DE602005026113D1 (pt)
DK (1) DK1737945T3 (pt)
EA (1) EA010576B1 (pt)
MX (1) MXPA06011568A (pt)
NO (1) NO20065290L (pt)
NZ (1) NZ549835A (pt)
WO (1) WO2005100542A1 (pt)
ZA (1) ZA200607622B (pt)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102031258A (zh) * 2004-04-19 2011-04-27 艾文蒂斯药品公司 纯化质粒dna的方法
PT2153260T (pt) * 2007-05-23 2017-04-24 Vgxi Inc Composição que compreende uma alta concentração de moléculas biologicamente ativas e processos de preparação da mesma
AU2009242587B2 (en) 2008-04-30 2015-05-28 Strike Bio, Inc. Highly pure plasmid DNA preparations and processes for preparing the same
US9149772B2 (en) 2010-01-15 2015-10-06 Board Of Regents, The University Of Texas Systems Enhancing flux of a microporous hollow fiber membrane
BR112012017563A2 (pt) 2010-01-15 2016-08-16 Univ Texas processo não dispersivo para recuperação de óleo insolúvel em suspensões aquosas
US9782726B2 (en) 2010-01-15 2017-10-10 Board Of Regents, The University Of Texas System Non-dispersive process for oil recovery
US9688921B2 (en) 2013-02-26 2017-06-27 Board Of Regents, The University Of Texas System Oil quality using a microporous hollow fiber membrane
US9643127B2 (en) 2010-01-15 2017-05-09 Board Of Regents Of The University Of Texas System Simultaneous removal of oil and gases from liquid sources using a hollow fiber membrane
US8491792B2 (en) 2010-01-15 2013-07-23 Board Of Regents, The University Of Texas System Non-dispersive process for insoluble oil recovery from aqueous slurries
US8617396B2 (en) 2010-01-15 2013-12-31 Board Of Regents, The University Of Texas System Non-dispersive process for insoluble oil recovery from aqueous slurries
US20130115598A1 (en) * 2011-10-13 2013-05-09 Lawrence Loeb Oligonucleotide probe retrieval assay for dna transactions in mammalian cells
GB2497575A (en) * 2011-12-15 2013-06-19 Protein Technologies Ltd Cell lysis in a flowing liquid using a lytic agent
WO2013188849A1 (en) 2012-06-14 2013-12-19 Board Of Regents, The University Of Texas System Non-dispersive oil recovery from oil industry liquid sources
EP2682168A1 (en) 2012-07-02 2014-01-08 Millipore Corporation Purification of biological molecules
CN104370997B (zh) * 2014-09-24 2018-07-31 陈辉 去除生物制品中细菌内毒素的试剂盒、方法及其生物制品的制备方法
CN106884011B (zh) * 2015-12-16 2020-11-17 固安鼎泰海规生物科技有限公司 一种规模化质粒纯化的联合液相层析分离方法
WO2017186815A1 (en) * 2016-04-26 2017-11-02 Proqr Therapeutics Ii B.V. Antisense oligonucleotides for enhanced expression of frataxin
CN109641928B (zh) * 2016-06-14 2022-08-30 比奥根Ma公司 用于寡核苷酸纯化的疏水性相互作用色谱法
CN106554956A (zh) * 2016-12-07 2017-04-05 安徽智飞龙科马生物制药有限公司 一种产业化制备BCG‑CpG‑DNA的方法
GB201710130D0 (en) 2017-06-26 2017-08-09 Ge Healthcare Bioprocess R & D Ab A Method of seperation
CN111050903B (zh) * 2017-08-25 2023-02-28 积水医疗株式会社 甲基化dna分离和/或检测用色谱用填充剂
CN108531563A (zh) * 2018-02-05 2018-09-14 深圳市尚维高科有限公司 多孔微球的用途及裂解液以及裂解液的使用方法
CN110348090B (zh) * 2019-06-28 2021-05-04 浙江大学 基于人工神经网络实现多柱连续流层析设计及分析的方法
CN111088248B (zh) * 2019-12-23 2020-10-16 广州湾区生物科技有限公司 一种用于提取无内毒素质粒的磁性材料及其使用方法
CN111394427B (zh) * 2020-04-22 2023-04-11 宁波市博坤生物科技有限公司 一种含泥土检材中微量dna的提取方法
CN112798697B (zh) * 2020-11-16 2022-11-22 武汉波睿达生物科技有限公司 慢病毒包装系统辅助质粒的超螺旋结构纯度的检测方法
CN115404232A (zh) * 2021-05-10 2022-11-29 艾棣维欣(苏州)生物制品有限公司 用于提取细菌中质粒dna的方法
CN115404154A (zh) * 2021-05-10 2022-11-29 艾棣维欣(苏州)生物制品有限公司 用于提取细菌中质粒dna的装置
WO2023025208A1 (zh) * 2021-08-24 2023-03-02 赛斯尔擎生物技术(上海)有限公司 一种修饰细胞的方法
CN114085828A (zh) * 2021-11-17 2022-02-25 安徽荃银高科种业股份有限公司 一种水稻基因组dna的快速低成本提取方法及其应用
JPWO2023095665A1 (pt) * 2021-11-29 2023-06-01
EP4234695A1 (en) * 2022-02-24 2023-08-30 Sartorius BIA Separations d.o.o. Methods for the selective removal of contaminants during a process of purifying biologic agents
CN116987581A (zh) * 2023-08-08 2023-11-03 江苏耀海生物制药有限公司 一种质粒dna制备装置及制备工艺

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5561064A (en) * 1994-02-01 1996-10-01 Vical Incorporated Production of pharmaceutical-grade plasmid DNA
FR2728264B1 (fr) * 1994-12-16 1997-01-31 Rhone Poulenc Rorer Sa Purification d'adn par formation de triple helice avec un oligonucleotide immobilise
ATE268810T1 (de) * 1995-12-21 2004-06-15 Genzyme Corp Methode zur zellyse
FR2746412B1 (fr) * 1996-03-21 1998-06-12 Rhone Poulenc Rorer Sa Purification d'adn plasmidique de qualite pharmaceutique
US7026468B2 (en) * 1996-07-19 2006-04-11 Valentis, Inc. Process and equipment for plasmid purification
US7807822B2 (en) * 1996-08-01 2010-10-05 Robert Bridenbaugh Methods for purifying nucleic acids
FR2773818B1 (fr) * 1998-01-21 2000-02-18 Pasteur Merieux Serums Vacc Procede et dispositif de lyse de bacteries
EP1187840B2 (en) * 1999-05-28 2012-12-19 Lonza Biologics Inc. Methods of dna purification
AU2001263459B2 (en) * 2000-05-26 2007-03-15 Centelion S.A.S. Purification of a triple heli formation with an immobilized oligonucleotide
WO2002023161A1 (en) * 2000-09-18 2002-03-21 University Of Washington Microfluidic devices for rotational manipulation of the fluidic interface between multiple flow streams
US20040002081A1 (en) * 2001-12-18 2004-01-01 Boehringer Ingelheim International Gmbh And Bia Separations D.O.O. Method and device for isolating and purifying a polynucleotide of interest on a manufacturing scale
AU2003293042A1 (en) * 2002-12-23 2004-07-29 Vical Incorporated Process for purification of plasmid dna
NZ545449A (en) * 2003-09-17 2009-07-31 Centelion Formerly Gencell Sas Device and Method of preparation of pharmaceutical grade plasmid DNA
CN102031258A (zh) * 2004-04-19 2011-04-27 艾文蒂斯药品公司 纯化质粒dna的方法

Also Published As

Publication number Publication date
JP2011132249A (ja) 2011-07-07
MXPA06011568A (es) 2006-12-20
DE602005026113D1 (de) 2011-03-10
NZ549835A (en) 2008-12-24
DK1737945T3 (da) 2011-05-09
AU2011200978A1 (en) 2011-04-07
EA200601728A1 (ru) 2007-04-27
CA2559368A1 (en) 2005-10-27
AU2005233309A1 (en) 2005-10-27
CN101006170A (zh) 2007-07-25
AU2005233309B2 (en) 2011-03-31
KR20060135062A (ko) 2006-12-28
EA010576B1 (ru) 2008-10-30
JP2007532123A (ja) 2007-11-15
WO2005100542A1 (en) 2005-10-27
ZA200607622B (en) 2008-05-28
BRPI0509490A (pt) 2007-09-11
US20070213289A1 (en) 2007-09-13
ATE496990T1 (de) 2011-02-15
CN102031258A (zh) 2011-04-27

Similar Documents

Publication Publication Date Title
NO20065290L (no) Fremgangsmate for a rense plasmid-DNA
HK1096994A1 (en) Method of preparation of pharmaceutically grade plasmid dna
WO2009025690A3 (en) Improved e. coli plasmid dna production
WO2006083721A3 (en) Purification process for piasmid dna
GB2575930A (en) Nucleobase editors comprising nucleic acid programmable DNA binding proteins
CA2270106A1 (en) Nucleic acid purification and process
WO2003040687A3 (en) Isolation and purification of nucleic acids
US20080299621A1 (en) Miniprep system for simple and rapid plasmid dna extraction
PT1232502E (pt) Particulas de vidro magneticas, metodo para a sua preparacao e suas utilizacoes
WO2007017229A3 (de) Verfahren für die kontinuierliche zielgerichtete evolution von proteinen in vitro
MY188566A (en) Method to improve virus removal in protein purification
WO2014005014A3 (en) Purification of iduronate-2-sulfatase
WO2008085962A3 (en) Cell culture methods for producing recombinant proteins in the presence of reduced levels of one or more contaminants
MX341243B (es) Formulacion que comprende una enzima de degradacion de proteoglicano.
Pereira et al. New approach for purification of pre-miR-29 using lysine-affinity chromatography
CY1111401T1 (el) Μεθοδος καθαρισμου πλασμιδιακου dna
WO2008073688A3 (en) Improved expression system for recombinant human arginase i
DK1242442T3 (da) Fremgangsmåde til skalerbar oprensning af plasmid-DNA
WO2004081166A3 (de) Nukleotidsequenzen coryneformer bakterien codierend für am l-serinstoffwechsel beteiligte proteine sowie verfahren zur mikrobiellen herstellung von l-serin
Zhong et al. Developing an RNase-free bioprocess to produce pharmaceutical-grade plasmid DNA using selective precipitation and membrane chromatography
WO2006026125A3 (en) Improved strains of e. coli for plasmid dna production
Chowdhury et al. Rapid isolation of high quality, multimeric plasmid DNA using zwitterionic detergent
Guerrero‐Germán et al. Purification of plasmid DNA from Escherichia coli ferments using anion‐exchange membrane and hydrophobic chromatography
WO2006081529A3 (en) Compositions and processes for improved plasmid dna production
WO2005072092A3 (en) Systems for tightly regulated gene expression

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application